Akebia Therapeutics, Inc.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Akebia Therapeutics, Inc. (“Akebia” or “the Company”) (NASDAQ: AKBA) who formerly held shares of Keryx Biopharmaceuticals, Inc. (KERX) for violations of the securities laws.

-->

Bayerische Motoren Werke AG

According to the Complaint, the Company made false and misleading statements to the market. BMW engaged in a scheme in which a “bank” of retail vehicle sales was maintained to manipulate monthly sales to meet internal targets regardless of actual sales. The Company manipulated its sales figures by having dealers register vehicles still held in inventory as sold. The Company’s key operating metrics were inflated and misleading due to this scheme. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about BMW, investors suffered damages.

-->

Precigen, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Precigen used pure methane in place of natural gas as feedstock for its methanotroph bioconversion platform, producing a high yield. In fact, the yield from natural gas was considerably lower. Pure methane was not a commercially viable feedstock based on its high price compared to natural gas. The Company was under investigation by the SEC since October 2018. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Precigen, investors suffered damages.

-->

LexinFintech Holdings Ltd.

According to the Complaint, the Company made false and misleading statements to the market. LexinFintech engaged in a scheme to report an artificially low delinquency rate by giving borrowers in danger of default funds to make payments. The Company prioritized Chinese lenders for certain transactions, exposing shareholders to huge risk. The Company exaggerated its user base and helped its actual users to engage in peer to peer lending contrary to local laws. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about LexinFintech, investors suffered damages.

-->

CBOE Volatility Index

According to the Complaint, the Company issued false and/or misleading statements and/or failed to disclose that: CBOE participated with others to manipulate the VIX “fear gauge” in a systematic manner during the 2004 to 2018 timeframe, causing economic damages to investors who traded in VIX futures, options and certain other VIX derivatives. As a consequence of these activities, the complaint alleges that CBOE and a few of its preferred traders violated the Securities Exchange Act of 1934, the Commodity Exchange Act and the Sherman Act. When the truth was revealed to the investing public, shares fell, causing shareholders harm.

-->